Processa Pharmaceuticals, Inc. Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations
Processa Pharmaceuticals, Inc. (PCSA) had Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations of $2.85 million as of 2017-12-31, per its 10-Q filed 2018-08-14.
Discontinued › Cash Flow › Cash
us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations · last filed 2018-08-14
- 2017-12-31: Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations $2.85M.
- 2017-09-30: Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations $80.26K.
- 2017-06-30: Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations $1.95K.
- 2017-03-31: Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations $1.64K.
| Period end | Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations | Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations as first filed |
|---|---|---|
| 2017-12-31 | $2.85M 10-Q · filed 2018-08-14 | |
| 2017-09-30 | $80.26K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $1.95K 10-Q · filed 2017-10-04 | |
| 2017-03-31 | $1.64K 10-Q · filed 2017-10-04 | |
| 2016-12-31 | $1.07M 10-Q · filed 2018-08-14 | $3.24K 10-K · filed 2017-09-25 |
| 2016-09-30 | $10.23K 10-Q · filed 2017-11-20 | |
| 2016-06-30 | $18.50K 10-Q · filed 2017-10-04 | |
| 2016-03-31 | $6.07K 10-Q · filed 2017-10-04 | |
| 2015-12-31 | $14.44K 10-Q · filed 2017-11-20 | |
| 2015-09-30 | $15.10K 10-Q · filed 2017-09-08 | |
| 2015-06-30 | $15.19K 10-Q · filed 2017-08-30 | |
| 2015-03-31 | $41.78K 10-Q · filed 2017-08-07 | |
| 2014-12-31 | $25.04K 10-K · filed 2017-09-25 | |
| 2013-12-31 | $186.86K 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |